Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

After the 2 weeks acclimatization to the diet, at the time of the xenograft inoculation, in the low vitamin D group the plasma 25‐D3 levels were already decreased (29.7 ± 4.2 nmol/l, data not shown) while at the end of the experiment the 25‐D3 levels were below detection limit (<10 nmol/l) (Fig. 4 a).

Source: Effects of vitamin D3 and soy supplementation on plasma levels of 25‐D3, calcium and renal vitamin D metabolism. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Cells were cultured for more than one month to select for stably transfected clones.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy

Study design awaiting verification · International Journal of Cancer · 2015

Original publication title

Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy

Julia Höbaus; Samawansha Tennakoon; Petra Heffeter; Charlotte Groeschel; Abhishek Aggarwal; Doris M. Hummel; Ursula Thiem; Rodrig Marculescu; Walter Berger; Enikö Kállay

© 2015 The Authors International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Our previous studies showed that the 1,25‐dihydroxyvitamin D (1,25‐D3) catabolizing enzyme, 1,25‐dihydoxyvitamin D 24 hydroxylase (CYP24A1) was overexpressed in colorectal tumours and its level correlated with increased proliferation. We hypothesised that cells overexpressing CYP24A1 have growth advantage and a diet rich in vitamin D and soy would restore sensitivity to the anti‐tumourigenic effects of vitamin D. Soy contains genistein, a natural CYP24A1 inhibitor. To determine causality between CYP24A1 and tumour growth, we established xenografts in male SCID mice with HT29 cells stably overexpressing either GFP‐tagged CYP24A1 or GFP.

Mice were fed with either high (2500 IU D3/kg) or low vitamin D (100 IU D3/kg) diet in the presence or absence of soy (20% diet). In vitro, cells overexpressing CYP24A1 grew faster than controls. 1,25‐D3, the active vitamin D metabolite, reduced cell number only in the presence of the CYP24A1 inhibitor VID400. Regardless of the amount of vitamin D in the diet, xenografts overexpressing CYP24A1 grew faster, were heavier and more aggressive. Soy reduced tumour volume only in the control xenografts, while the tumours overexpressing CYP24A1 were larger in the presence of dietary soy.

In conclusion, we demonstrate that CYP24A1 overexpression results in increased aggressiveness and proliferative potential of colorectal tumours. Irrespective of the dietary vitamin D3, dietary soy is able to increase tumour volume when tumours overexpress CYP24A1, suggesting that combination of vitamin D3 and soy could have an anti‐tumourigenic effect only if CYP24A1 levels are normal.

What's new?

Vitamin D3 supplementation is linked to reduced tumour growth in the colon, but colorectal tumours may also overexpress the vitamin‐D‐degrading enzyme CYP24A1, potentially undermining the benefits of vitamin D intake. We show that in a mouse xenograft model, CYP24A1 overexpression confers growth advantage to colorectal tumours, regardless of vitamin D intake. Combination of dietary vitamin D and soy increases volume and weight of tumours overexpressing CYP24A1. The findings warrant exploration of the effects of specific CYP24A1 inhibitors in CYP24A1‐overexpressing colorectal tumours.

Authors’ abstract

Our previous studies showed that the 1,25‐dihydroxyvitamin D (1,25‐D3) catabolizing enzyme, 1,25‐dihydoxyvitamin D 24 hydroxylase (CYP24A1) was overexpressed in colorectal tumours and its level correlated with increased proliferation. We hypothesised that cells overexpressing CYP24A1 have growth advantage and a diet rich in vitamin D and soy would restore sensitivity to the anti‐tumourigenic effects of vitamin D. Soy contains genistein, a natural CYP24A1 inhibitor. To determine causality between CYP24A1 and tumour growth, we established xenografts in male SCID mice with HT29 cells stably overexpressing either GFP‐tagged CYP24A1 or GFP.

Mice were fed with either high (2500 IU D3/kg) or low vitamin D (100 IU D3/kg) diet in the presence or absence of soy (20% diet). In vitro, cells overexpressing CYP24A1 grew faster than controls. 1,25‐D3, the active vitamin D metabolite, reduced cell number only in the presence of the CYP24A1 inhibitor VID400. Regardless of the amount of vitamin D in the diet, xenografts overexpressing CYP24A1 grew faster, were heavier and more aggressive. Soy reduced tumour volume only in the control xenografts, while the tumours overexpressing CYP24A1 were larger in the presence of dietary soy.

In conclusion, we demonstrate that CYP24A1 overexpression results in increased aggressiveness and proliferative potential of colorectal tumours. Irrespective of the dietary vitamin D3, dietary soy is able to increase tumour volume when tumours overexpress CYP24A1, suggesting that combination of vitamin D3 and soy could have an anti‐tumourigenic effect only if CYP24A1 levels are normal.

What's new?

Vitamin D3 supplementation is linked to reduced tumour growth in the colon, but colorectal tumours may also overexpress the vitamin‐D‐degrading enzyme CYP24A1, potentially undermining the benefits of vitamin D intake. We show that in a mouse xenograft model, CYP24A1 overexpression confers growth advantage to colorectal tumours, regardless of vitamin D intake. Combination of dietary vitamin D and soy increases volume and weight of tumours overexpressing CYP24A1. The findings warrant exploration of the effects of specific CYP24A1 inhibitors in CYP24A1‐overexpressing colorectal tumours.

Publication and source details

Original title: Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy

Julia Höbaus; Samawansha Tennakoon; Petra Heffeter; Charlotte Groeschel; Abhishek Aggarwal; Doris M. Hummel; Ursula Thiem; Rodrig Marculescu; Walter Berger; Enikö Kállay

International Journal of Cancer · 2015

* Correspondence to: Prof. Enikö Kállay, Medical University of Vienna, Department of Pathophysiology and Allergy Research, Währinger Gürtel 18‐20, A‐1090, Vienna, Austria, Tel: 43‐1‐40400‐51230, Fax: 43‐1‐40400‐51300, E‐mail: enikoe.kallay@meduniwien.ac.at
†

J.H. and S.T. contributed equally to this work.

© 2015 The Authors International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICChttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Austrian Society of Bone and Mineral Research (Felix Bronner Dissertation Stipendium for JH) Austrian Science Fond (FWF) P22200‐B11 Vienna Science and Technology Fund (WWTF) LS12‐047 EU FP7‐PEOPLE‐2010‐ITN 264663

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:53:52.624535+00:00

DOI: 10.1002/ijc.29717 · PMC4832261